HDAC3 and hepatoblastoma: Other HDACs, including HDAC3, 8, and 4 were expressed at lower levels than HDAC1 and 2. These data suggest that HDAC1 and 2 could be the possible therapeutic target of HDAC inhibitors in hepatoblastoma.